Data / Drug companies / Triamterene and hydrochlorothiazide
Triamterene and hydrochlorothiazide: 27 companies and 69 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Triamterene and hydrochlorothiazide is listed in the FDA National Drug Code Directory by 27 companies, with 69 products in commercial distribution. 69 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, and the newest product started marketing on June 2, 2025.
The request: Get every company that lists triamterene and hydrochlorothiazide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 27
- Products
- 69
- Generic (ANDA) products
- 69 (100.0%)
- Application numbers
- 9
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list triamterene and hydrochlorothiazide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 8 | tablet; capsule | Generic drugs (ANDA) | February 21, 2020 |
| Bryant Ranch Prepack | 8 | tablet; capsule | Generic drugs (ANDA) | February 23, 2022 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet; capsule | Generic drugs (ANDA) | February 21, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | September 4, 2018 |
| BluePoint Laboratories | 4 | tablet | Generic drugs (ANDA) | June 18, 2019 |
| Northwind Health Company, LLC | 3 | tablet; capsule | Generic drugs (ANDA) | December 26, 2023 |
| Northwind Health Company, LLC | 3 | tablet; capsule | Generic drugs (ANDA) | December 30, 2022 |
| Preferred Pharmaceuticals Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | June 17, 2024 |
| Remedyrepack Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | June 2, 2025 |
| Zydus Lifesciences Limited | 3 | tablet; capsule | Generic drugs (ANDA) | March 3, 2020 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet; capsule | Generic drugs (ANDA) | March 31, 2019 |
| Actavis Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | September 23, 1993 |
| Advagen Pharma Ltd | 2 | tablet | Generic drugs (ANDA) | February 23, 2022 |
| Apotex Corp. | 2 | tablet | Generic drugs (ANDA) | September 21, 2009 |
| Bryant Ranch Prepack | 2 | capsule; tablet | Generic drugs (ANDA) | June 5, 1997 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | September 23, 1993 |
| Proficient Rx LP | 2 | capsule | Generic drugs (ANDA) | December 12, 2011 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | March 21, 2016 |
| Bryant Ranch Prepack | 1 | capsule | Generic drugs (ANDA) | December 9, 2011 |
| Chartwell RX, LLC | 1 | capsule | Generic drugs (ANDA) | December 9, 2011 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | May 5, 1998 |
| Macleods Pharmaceuticals Limited | 1 | capsule | Generic drugs (ANDA) | January 28, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | September 21, 2009 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | February 21, 2020 |
| Sandoz Inc | 1 | capsule | Generic drugs (ANDA) | June 5, 1997 |
| St. Mary's Medical Park Pharmacy | 1 | capsule | Generic drugs (ANDA) | May 5, 2022 |
| Viona Pharmaceuticals Inc | 1 | capsule | Generic drugs (ANDA) | February 21, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 45 | 65.2% |
| Capsule | 24 | 34.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 69 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Potassium-sparing Diuretic | 69 |
| Thiazide Diuretic | 69 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.